Skip to content

Clinical trials

Terminated Lung Diseases, Interstitial trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Terminated Country / region: Germany Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20121
20151
20171
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
Furiex Pharmaceuticals, Inc1
Gilead Sciences1
Kyntra Bio1
Matthias Griese1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial6
Idiopathic Pulmonary Fibrosis3
Idiopathic Interstitial Pneumonias2
Pulmonary Fibrosis2
Respiratory Tract Diseases2
Bacterial Infections1
Community-Acquired Infections1
Fibrosis1
Lung Diseases1
Pathologic Processes1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.